Authors:
Waldman, WJ
Bickerstaff, A
Gordillo, G
Orosz, K
Knight, DA
Orosz, CG
Citation: Wj. Waldman et al., Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide, TRANSPLANT, 72(9), 2001, pp. 1578-1582
Authors:
Knight, DA
Hejmanowski, AQ
Dierksheide, JE
Williams, JW
Chong, ASF
Waldman, WJ
Citation: Da. Knight et al., Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide, TRANSPLANT, 71(1), 2001, pp. 170-174
Authors:
Knight, DA
Briggs, BR
Bennett, CF
Harindranath, N
Waldman, WJ
Sedmak, DD
Citation: Da. Knight et al., Attenuation of cytomegalovirus-induced endothelial intercellular adhesion molecule-1 mRNA/protein expression and T lymphocyte adhesion by a 2 '-O-methoxyethyl antisense oligonucleotide, TRANSPLANT, 69(3), 2000, pp. 417-426
Authors:
Waldman, WJ
Knight, DA
Blinder, L
Shen, JK
Lurain, NS
Miller, DM
Sedmak, DD
Williams, JW
Chong, ASF
Citation: Wj. Waldman et al., Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide, INTERVIROLO, 42(5-6), 1999, pp. 412-418
Citation: Wj. Waldman et al., Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide, TRANSPLANT, 68(6), 1999, pp. 814-825
Citation: Da. Knight et al., Cytomegalovirus-mediated modulation of adhesion molecule expression by human arterial and microvascular endothelial cells, TRANSPLANT, 68(11), 1999, pp. 1814-1818
Citation: Dm. Miller et al., Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction, J IMMUNOL, 162(10), 1999, pp. 6107-6113